6 results
Glucagon: Bypassing β-Blockade

Glucagon pathophysiology and clinical applications in anaphylaxis and beta-blocker overdose

#Toxicology #Pharmacology #Pathophysiology #Glucagon #BetaBlocker
β-Blockade Glucagon pathophysiology ... and clinical applications ... #Toxicology #Pharmacology ... #Pathophysiology ... #Glucagon #BetaBlocker
Beta blocker Conversion Table- Carvedilol, Metoprolol and Bisoprolol Equivalents
Converting between Beta-Blockers: Carvedilol, Metoprolol and Bisoprolol

#Pharmacology #Cardiology
blocker Conversion Table ... #Cardiology #BetaBlocker ... #Conversion #Table ... Recommended Text: Clinical ... Pharmacology Made
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... million new M. tuberculosis ... (LTBI) Pathophysiology ... Immunosuppression • Tumor ... characteristic features Clinical
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... million new M. tuberculosis ... (LTBI) Pathophysiology ... Immunosuppression • Tumor ... characteristic features Clinical
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Clinically Significant ... Increases effects of betablockers ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... HIV-infected persons with clinical ... Please refer to the table ... Mycobacterium #Tuberculosis ... infections #HIVAIDS #pharmacology